February 2012

CRANBURY, N.J., Feb. 15, 2012 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced results for its second quarter ended December 31, 2011.  Palatin reported a net loss of $2.6 million, or $(0.08) …

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be Held on February 15, 2012 Read More »

CRANBURY, N.J., Feb. 9, 2012 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) announced that it will be presenting at the 14th Annual BIO CEO & Investor Conference on Monday, February 13, 2012 at 8:30 a.m. ET.  Hosted by the Biotechnology Industry Organization (BIO), the 14th Annual BIO CEO & Investor Conference will take place …

Palatin Technologies to Present at 14th Annual BIO CEO & Investor Conference Read More »

CRANBURY, N.J., Feb. 8, 2012 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its second quarter, fiscal year 2012 financial results on Wednesday, February 15, 2012 before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February …

Palatin Technologies, Inc. to Report Fiscal Year 2012 Second Quarter Results; Teleconference and Webcast to be Held on February 15, 2012 Read More »